Ferring Pharmaceuticals purchased ex-U.S. assets and rights to Apricus Biosciences’ on-demand topical erectile dysfunction therapy cream Vitaros ® (alprostadil) for potentially $12.7 million. Ferring ...
SAN DIEGO, March 31, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI), announced today that the Mexican Patent Office ("MPO") will grant an additional patent for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback